Market Overview:
The global blepharitis market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of blepharitis, rising awareness about the condition, and technological advancements in treatment options. The global blepharitis market is segmented on the basis of type, application, and region. On the basis of type, it is divided into antibiotics, steroids, and other drugs. The antibiotics segment accounted for the largest share of the global blepharitis market in 2017 owing to their high efficacy in treating various forms of blepharitis. On the basis of application, it is classified into monotherapy and combination drug therapy.
Product Definition:
Blepharitis is a condition that results in inflammation of the eyelids. It can cause symptoms such as redness, itching, and crusting around the eyes. Blepharitis can be treated with warm compresses, lid scrubs, and antibiotics if needed.
Antibiotics:
Antibiotics Market is expected to grow at a significant rate over the forecast period owing to rising prevalence of bacterial infection in patients with blepharitis. Bacterial infection may lead to permanent blindness if not treated on time. According to the study published by American Academy of Ophthalmology, approximately 300,000 people are affected by this condition every year and around 50% of them recover within few months without any treatment.
Steroids:
Steroids are man-made body chemicals that are extracted from animal or plant sources. They can be administered in the form of injections, oral tablets, transdermal patches or as eye drops. Steroids can treat conditions such as eczema (atopic dermatitis), psoriasis and blepharitis (irritation of eyelid). However, steroids cannot cure these diseases but they can ease the symptoms for a short period.
Application Insights:
Based on the application, the market is segmented into monotherapy, combination therapy and others. Blepharitis dominated by monotherapy as of 2017 owing to rising prevalence of diseases such as acne and sebostasis. In addition, increasing number of clinical trials for antibiotic-based products will boost product demand in this segment over the forecast period.
The other application segment includes treatment of chronic styes and eyelid surgery preps for cosmetic procedures such as blepharoplasty or orbital fat grafting. The rise in popularity of these procedures is expected to drive market growth over the forecast period. However, high cost associated with these surgeries may hinder industry growth in some regions during future years due to increase competition among healthcare providers resulting in low revenue generation capacity for pharmaceutical companies operating within a given region.
Regional Analysis:
Europe dominated the global market in 2017. The presence of a large number of manufacturers and suppliers, availability of advanced products, high awareness levels about available treatment options, and supportive reimbursement framework are some factors attributing to its largest share. In addition, increasing prevalence of eye disorders is also expected to contribute toward regional growth over the forecast period.
Asia Pacific is anticipated to witness significant growth during the forecast period owing to rising disposable income levels and improving healthcare infrastructure in emerging countries such as China & India. Growing geriatric population coupled with an increase in chronic diseases such as blepharitis that are more prevalent among this group will further drive regional demand for antibiotic products over the next eight years. However, stringent regulatory policies regarding product approval by respective governments may hinder industry expansion at certain instances; therefore restraining overall revenue generation from 2018 to 2030 (Ref).
In Japan alone around 1 million people suffer from blepharitis annually (Ref.).
Growth Factors:
- Increasing prevalence of blepharitis
- Growing awareness about the condition and its treatment options
- Rising demand for ophthalmic products and services
- Technological advancements in blepharitis treatment methods
- Growing number of research studies on the condition
Scope Of The Report
Report Attributes
Report Details
Report Title
Blepharitis Market Research Report
By Type
Antibiotics, Steroids, Other
By Application
Monotherapy, Combination Drug Therapy
By Companies
Bausch Health, Allergan, Novartis, LABORATORIES THEA, Akorn, NovaBay Pharmaceuticals, Scope Ophthalmics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
160
Number of Tables & Figures
112
Customization Available
Yes, the report can be customized as per your need.
Global Blepharitis Market Report Segments:
The global Blepharitis market is segmented on the basis of:
Types
Antibiotics, Steroids, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Monotherapy, Combination Drug Therapy
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bausch Health
- Allergan
- Novartis
- LABORATORIES THEA
- Akorn
- NovaBay Pharmaceuticals
- Scope Ophthalmics
Highlights of The Blepharitis Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Antibiotics
- Steroids
- Other
- By Application:
- Monotherapy
- Combination Drug Therapy
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Blepharitis Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Blepharitis is an inflammation of the eyelid. It can be caused by a variety of factors, including contact lenses, allergies, and environmental exposure. Blepharitis often causes redness and swelling around the eyes.
Some of the major players in the blepharitis market are Bausch Health, Allergan, Novartis, LABORATORIES THEA, Akorn, NovaBay Pharmaceuticals, Scope Ophthalmics.
The blepharitis market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Blepharitis Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Blepharitis Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Blepharitis Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Blepharitis Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Blepharitis Market Size & Forecast, 2020-2028
4.5.1 Blepharitis Market Size and Y-o-Y Growth
4.5.2 Blepharitis Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Antibiotics
5.2.2 Steroids
5.2.3 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Monotherapy
6.2.2 Combination Drug Therapy
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Blepharitis Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Blepharitis Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Antibiotics
9.6.2 Steroids
9.6.3 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Monotherapy
9.10.2 Combination Drug Therapy
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Antibiotics
10.6.2 Steroids
10.6.3 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Monotherapy
10.10.2 Combination Drug Therapy
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Antibiotics
11.6.2 Steroids
11.6.3 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Monotherapy
11.10.2 Combination Drug Therapy
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Antibiotics
12.6.2 Steroids
12.6.3 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Monotherapy
12.10.2 Combination Drug Therapy
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Antibiotics
13.6.2 Steroids
13.6.3 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Monotherapy
13.10.2 Combination Drug Therapy
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Blepharitis Market: Competitive Dashboard
14.2 Global Blepharitis Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bausch Health
14.3.2 Allergan
14.3.3 Novartis
14.3.4 LABORATORIES THEA
14.3.5 Akorn
14.3.6 NovaBay Pharmaceuticals
14.3.7 Scope Ophthalmics
